Hongos Alucinógenos y Psilocibina: La Ciencia Detrás del Viaje Psicodélico. Ep. 63 скачать в хорошем качестве

Hongos Alucinógenos y Psilocibina: La Ciencia Detrás del Viaje Psicodélico. Ep. 63

Elizabeth García nos habla de los hongos alucinógenos y la psilocibina, el cómo esta sustancia presente en dichos hongos puede ser parte del tratamiento de ciertas enfermedades mentales. Visita nuestra web www.citologiacienciayarte.com Articulos cientificos que pueden consultar Carhart-Harris, R. L., et al. (2016). "Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study." The Lancet Psychiatry. Griffiths, R. R., et al. (2016). "Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial." Journal of Psychopharmacology. Johnson, M. W., et al. (2014). "Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction." Journal of Psychopharmacology. Griffiths, R. R., et al. (2006). "Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance." Psychopharmacology. Carhart-Harris, R. L., & Goodwin, G. M. (2017). "The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future." Neuropsychopharmacology. Ross, S., et al. (2016). "Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial." Journal of Psychopharmacology. Pollan, M. (2018). "How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence." Penguin Press. "The New England Journal of Medicine" (2021). "Trial of Psilocybin versus Escitalopram for Depression."